No Detail Found!

Carbamazepine Verses Valproic Acid as Monotherapy in Epileptic Patients.

Author(s)
Shakirullah Shakir Department of Pharmacology, Institute of Basic Medical Sciences, Khyber Medical University, Peshawar, Pakistan
Niaz Ali Department of Pharmacology, Institute of Basic Medical Sciences, Khyber Medical University, Peshawar, Pakistan
Haleema Nazish Department of Pharmacology, Institute of Basic Medical Sciences, Khyber Medical University, Peshawar, Pakistan
Abstract
Objective: To evaluate the effectiveness of carbamazepine and valproic acid as monotherapy in epileptic patients of Pakhtun population. Study Design: An experimental study. Place and Duration of Study: The outpatient Neurology Department, Lady Reading Hospital, Peshawar, from August 2014 to April 2016. Methodology: Epileptic patients placed on carbamazepine and volproic acid were inducted. Carbamazepine and valproic acid plasma levels were determined using reverse phase high performance liquid chromatography. Plasma levels of vitamin B6 and homocysteine were determined at baseline before the switching to carbamazepine and valproic acid therapy, and on the sixth month of the therapy. Hemoglobin (Hb) level were also determined through blood analyser. Clinical response (number of seizures per week) was evaluated on third and sixth month of the therapy. Results: There were 79 patients in carbamazepine group and 82 in the valproic acid group. Mean age of patients was 18.08 ±8.6 years in carbamazepine group and 17.5 ±7.04 years in the valproic acid group. Median dose of carbamazepine was 400 mg/day at baseline and at 6th month of therapy. Median dose of valproic acid was 500 mg/day and 750 mg/day of valproic acid at baseline and end study point. Difference in homocysteine, vitamin B6 and Hb levels were statistically significant (p<0.05) in carbamazepine cohort compared to valproic acid cohort. The frequency of seizures in the carbamazepine was 0.85 times more compared to valproic acid at the end study point. Conclusion: Hyperhomocysteinaemia and lower vitamin B6 and Hb levels was found in the carbamazepine cohort. The frequency of number of seizures/week was higher in the carbamazepine cohort compared to valproic acid cohort.
Publication Details
Page(s) 357-360
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 28, Issue: 5, Year: 2018

Request the full text from PASTIC

References
ChadwickD., 1994.Valproate in the treatment of partial epilepsies,Epilepsia 35 S96 -S8
GrünewaldRA,PanayiotopoulosCP, 1993.Juvenile myoclonic epilepsy: a review,Arch Neurol 50 594 -8
BourgeoisB,BeaumanoirA,BlajevB,CruzN,DesplandP,EgliM, 1987.Monotherapy with valproate in primary generalized epilepsies,Epilepsia 28 S8 -S11
KwanP,Brodie MJ, 2001.Effectiveness of first antiepileptic drug,Epilepsia 42 1255 -60
HungCC,ChangWL,HoJL,TaiJJ,HsiehTJ,HuangHC, 2012.Association of polymorphisms in EPHX1, UGT2B7, ABCB1, ABCC2, SCN1A and SCN2A genes with carbamazepine therapy optimization,Pharmacogenomics 13 159 -69
KasperaviciuteD,SisodiyaSM, 2009.Epilepsy pharmacogenetics,Pharmacogenomics 10 817 -36
SchmidtD,LöscherW. Drug, 2005.resistance in epilepsy: putative neurobiologic and clinical mechanisms,Epilepsia 46 858 -77
ChanE,LeeHS,HueSS, 2001.Population pharmacokinetics of carbamazepine in Singapore epileptic patients,Br J Clin Pharmacol 51 567 -76
PeruccaP,GilliamFG, 2012.Adverse effects of antiepileptic drugs,Lancet Neurol 11 792 -802
Asadi-PooyaAA,GhetmiriE., 2006.Folic acid supplementation reduces the development of some blood cell abnormalities in children receiving carbamazepine,Epilepsy Behav 8 228 -31
KurulS,ÜnalpA,YisU, 2007.Homocysteine levels in epileptic children receiving antiepileptic drugs,J Child Neurol 22 1389 -92
SenerU,ZorluY,KaraguzelO,OzdamarO,CokerI,TopbasM., 2006.Effects of common anti-epileptic drug monotherapy on serum levels of homocysteine, vitamin B12, folic acid and vitamin B6,Seizure 15 79 -85
ShiYW,MinFL,QinB,ZouX,LiuXR,GaoMM, 2012.Association between HLA and Stevens-Johnson syndrome induced by carbamazepine in Southern Han Chinese: genetic markers besides,B* 1502? Basic Clin Pharmacol Toxicol 111 58 -64
Reynolds E. Vitamin, 2006.B12, folic acid, and the nervous system,Lancet Neurol 5 949 -60
DordevicS,KilibardaV,StojanovicT., 2009.Determination of carbamazepine in serum and saliva samples by high performance liquid chromatography with ultraviolet detection,Vojnosanit Pregl 66 347 -52
BauerL.,McGraw-Hill, 2005.Clinical pharmacokinetics and pharmacodynamics. Pharmacotherapy: a pathophysiologic approach 6th ed, 51 -73
BelcastroV,StrianoP, 2012.Antiepileptic drugs, hyperhomocysteinemia and B-vitamins supplementation in patients with epilepsy,Epilepsy Res 102 1 -7
YingY,LiH,JinJ,LuX,FengP,SunY, 2017.Meta-analysis of the relationship between plasma homocysteine levels and carbamazepine monotherapy in patients with epilepsy,Iran Red Crescent Med J -
MintzerS,SkidmoreCT,SperlingMR, 2012.B-Vitamin deficiency in patients treated with antiepileptic drugs,Epilepsy Behav 24 341 -4
BhosaleUA,LoharkarNR,YegnanarayanR,QuraishiN., 2014.Study of effects of antiepileptic therapy on various biochemical and hematological parameters patients suffering of epilepsy,Int J Basic Clin Pharmacol 3 79 -85
BroshK,MatokI,SheinerE,KorenG,WiznitzerA,GorodischerR, 2010.Teratogenic determinants of first-trimester exposure to antiepileptic medications,J Popul Ther Clin Pharmacol 18 e89 -98
SelhubJ, 1999.Homocysteine metabolism,Annu Rev Nutr 19 217 -46
EbidA-HIM,AhmedMM,MohammedSA, 2007.Therapeutic drug monitoring and clinical outcomes in epileptic Egyptian patients: a gene polymorphism perspective study,Ther Drug Monit 29 305 -12
GabyAR, 2007.Natural approaches to epilepsy,Altern Med Rev 12 9 -
0

Citations

0

Downloads

96

Views